FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to 2-heterocyclyl-1,2-ethanediol carbamates of the formula (I) , their enantiomers, enantiomeric mixtures or pharmaceutically acceptable salts wherein A means a heterocyclic fragment chosen from the following group:
B1 and B2 mean independently hydroxy-group or -OCONR1R2 under condition that B1 and B2 don't mean hydroxy-group simultaneously; R1 and R2 mean hydrogen atom; R3, R4 and R5 mean alkyl, halogen atom, trihalogenmethyl, trialkylmethyl, -NO2, -CN and phenyl. These compounds can be used in treatment of the central nervous system disorders being especially as anticonvulsants and anti-epileptic agents. Also, invention describes a pharmaceutical composition based on compounds of the formula (I).
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
12 cl, 1 tbl, 34 ex
Authors
Dates
2007-05-10—Published
2002-06-18—Filed